Drug intelligence / Profile preview

Chuanbei Qing

Development stage: Unknown
Lead developer: Jichuan Pharmaceutical Group
Modality: Drug Delivery Systems, Small Molecules
Administration: Oral

Overview

Chuanbei Qing is an oral solution containing a concentrate of magnesium sulfate, sodium sulfate, and potassium sulfate. It is developed for intestinal preparation before colonoscopy in adult patients. These salts act as osmotic laxatives, drawing water into the bowel to induce watery diarrhea, thereby cleansing the colon for a clear view during the procedure. The drug is being studied in clinical trials by Jichuan Pharmaceutical Group Co. LTD and Peking Union Hospital, Chinese Academy of Medical Sciences.

Beyond the preview

Go deeper on Chuanbei Qing.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chuanbei Qing.

Explore the full profile